NEW YORK, Aug. 16 – Bioinformatics company Lion Bioscience of Heidelberg, Germany, said Thursday it had filed for patent protection for a series of lead compounds it had developed.
The announcement marks Lion’s first such application and comes just 16 months after the company launched its drug discovery efforts.